Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TRI-fraction Radiotherapy Utilized to Minimize Patient Hospital Trips : A Phase II Trial (TRIUMPH-T Trial)

NCT02526498 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.

NCT NCT02526498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02526498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TRI-fraction Radiotherapy Utilized to Minimize Patient Hospital Trips : A Phase II Trial (TRIUMPH-T Trial)
Lead sponsor
Rutgers, The State University of New Jersey
Phase
Phase 2
Overall status
Completed
Start date
July 15, 2015
Completion date
March 31, 2021
Enrollment
200 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

ductal breast carcinoma in situ, estrogen receptor positive, invasive breast carcinoma, progesterone receptor positive, stage ia breast cancer, stage ib breast cancer, stage iia breast cancer